To validate the binding of pentamers to CD8 T cells in MS brain sections, we performed double immunofluorescence stainings with anti-CD8 MAb and B*0801/BZLF1 or B*0801/EBNA3A pentamers. Here, CD8A is linked to myeloid sarcoma.